Testing effectiveness (Phase 2)Ended earlyNCT00060710What this trial is testingCP-461 in the Treatment of Patients With Advanced MelanomaWho this might be right forMalignant Melanoma Astellas Pharma Inc 35
Not applicableEnded earlyNCT00991991What this trial is testingStudy of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant MelanomaWho this might be right forMelanoma (Skin) Case Comprehensive Cancer Center 5
Not applicableEnded earlyNCT03825913What this trial is testing3-month Aerobic and Resistance Exercise Intervention for Individuals Diagnosed With MelanomaWho this might be right forMelanoma University of Miami 1
Not applicableStudy completedNCT01715077What this trial is testingStudy of Ipilimumab in the Immune SystemWho this might be right forPreviously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma University Health Network, Toronto 4
Not applicableNot Yet RecruitingNCT07689812What this trial is testingRandomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.Who this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more Natera, Inc. 920
Testing effectiveness (Phase 2)Looking for participantsNCT07288112What this trial is testingDOC1021 Dendritic Cell Immunotherapy for Refractory MelanomaWho this might be right forRefractory Melanoma Diakonos Oncology Corporation 35
Not applicableEnded earlyNCT02700763What this trial is testing[18F]Dabrafenib Molecular Imaging in Melanoma Brain MetastasisWho this might be right forMelanoma University Medical Center Groningen 1
Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Large-scale testing (Phase 3)WithdrawnNCT01826864What this trial is testingSargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II MelanomaWho this might be right forStage IB MelanomaStage IIA MelanomaStage IIB Melanoma+1 more Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05983237What this trial is testingFluzoparib in Combination With Camrelizumab and Temozolomide in Advanced MelanomaWho this might be right forMelanoma Jun Guo 50
Early research (Phase 1)Study completedNCT00001439What this trial is testingA Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's AdjuvantWho this might be right forMelanoma National Cancer Institute (NCI) 255
Early research (Phase 1)Study completedNCT00815607What this trial is testingTrial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV MelanomaWho this might be right forMelanoma Alaunos Therapeutics 12
Not applicableUnknownNCT06273709What this trial is testingRemote Assessment of OCT Scans for BCC DetectionWho this might be right forBasal Cell Carcinoma Maastricht University Medical Center 120
Not applicableStudy completedNCT05712551What this trial is testingDermoscopy Augmented Histology Trial, Consensus Agreement Diagnosis Made by Dermatopathology ExpertsWho this might be right forMelanoma (Skin)Pigmented Lesions Herlev Hospital 4
Early research (Phase 1)Study completedNCT00698100What this trial is testingVaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA VaccinesWho this might be right forMelanomaSkin Memorial Sloan Kettering Cancer Center 18
Not applicableStudy completedNCT03040492What this trial is testingVitamin D Receptor Polymorphisms and Non-Melanoma Skin Cancer RiskWho this might be right forSkin Cancer, Non-Melanoma University of Alabama at Birmingham 200
Testing effectiveness (Phase 2)Study completedNCT01248936What this trial is testingRO5185426 in Patients With Metastatic MelanomaWho this might be right forMalignant Melanoma Hoffmann-La Roche 374
Early research (Phase 1)Ended earlyNCT01216436What this trial is testingLocal Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic MelanomaWho this might be right forMetastatic Melanoma Duke University 2
Not applicableStudy completedNCT04435964What this trial is testingGender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatmentWho this might be right forMelanomaLung CancerHead and Neck Cancer+2 more Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 247
Early research (Phase 1)Study completedNCT00019175What this trial is testingVaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic MelanomaWho this might be right forMelanoma (Skin) National Cancer Institute (NCI)